Somalogic
The proteomics firm is working with four health providers to assess how its tests can improve delivery of care and to map out potential new use cases.
SomaLogic Launches Initiative Aimed at Demonstrating Clinical Value of SomaSignal Tests
The company plans to launch clinical trials in several disease areas with Emory University, Intermountain Healthcare, CommonSpirit Health and UCHealth.
SomaLogic to Go Public Through Merger With Special Purpose Acquisition Company
Following the transaction, which values the company at roughly $1.2 billion and will provide cash proceeds of around $650 million, SomaLogic will list on the Nasdaq.
Somalogic Adds $81M to Series A Round, Bringing Total to $214M
The funding adds to a $121 million raise the company announced last month and will go towards expanding and commercializing its SomaScan platform.
Somalogic Using $121M in Funding to Increase Accessibility of SomaScan Platform, Drive Dx Business
The firm has grown its SomaScan platform to measure 7,000 proteins and will have developed around 20 clinical tests on the platform by the end of the year.